AstraZeneca has announced that Koselugo (selumetinib), an oral, selective MEK inhibitor, has been recommended for approval in ...

China: A new meta-analysis published in Annals of Medicine suggests that constipation may be associated with an increased ...

Mississauga: Bayer Canada has announced a new partnership with Mint Pharmaceuticals Inc. for the distribution of ADALAT XL 30 ...

Patients who underwent video-assisted thoracoscopic surgery (VATS) compared to open lobectomy had a significantly improved ...

Researchers have found in a new study that aspartame and added sugars are associated with an increased risk of pediatric ...

Pelvic organ prolapse (POP) is a major healthcare issue characterised by the descent of one or more of the female pelvic ...

More pregnant people are turning away from hospital births and instead choosing their homes, according to research presented ...

USA: Periodic limb movements during sleep (PLMS) are common in children with obstructive sleep apnea (OSA), and their ...

New findings from the POSITIVE trial demonstrate that tildrakizumab (Ilumya/Ilumetri) not only delivers strong skin clearance ...

Next to cancer recurrence or progression, cardiovascular diseases are the leading causes of death in cancer survivors. The ...

Delhi Bench, has set aside the 80% disallowance of travelling and conveyance expenses imposed on Mankind Pharma Limited ...

A new systematic review published in the journal of Pediatric Allergy and Immunology confirmed that CARATkids is a reliable ...